Posted by
lsh in
What Is It on October 8, 2009 at 7:03 am

MENLO PARK, CA-- - Corcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders, has begun dosing in the Phase 1 study of its next-generation selective cortisol receptor antagonist, CORT 108297.Corcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders, has begun dosing in the Phase 1 study of its next-generation selective cortisol receptor antagonist, CORT 108297. "The initiation of the Phase 1 study of our lead selective cortisol receptor ...A decade ago psychologist Ronald Levant, then at Nova Southeastern University, was telling some of his colleagues at a conference about patients with schizophrenia whom he had seen recover. One of them asked rhetorically, “Recovery from schizophrenia? Have you lost your mind, too?” Until recently, virtually all experts agreed that schizophrenia is always, or almost always, marked by a steady ...
COMMENT
1 comments to "Cat Pizza"
See the rest of Neatorama: